Frances Lynch to Cost-Benefit Analysis
This is a "connection" page, showing publications Frances Lynch has written about Cost-Benefit Analysis.
Connection Strength
1.178
-
Cost-effectiveness of Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care. JAMA Netw Open. 2021 03 01; 4(3):e211778.
Score: 0.698
-
Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants. Pediatrics. 2018 02; 141(2).
Score: 0.141
-
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. Arch Gen Psychiatry. 2011 Mar; 68(3):253-62.
Score: 0.087
-
Cost-effectiveness of guided self-help treatment for recurrent binge eating. J Consult Clin Psychol. 2010 Jun; 78(3):322-33.
Score: 0.083
-
Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry. 2005 Nov; 62(11):1241-8.
Score: 0.060
-
Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services. Prev Med. 2004 Apr; 38(4):403-11.
Score: 0.054
-
The ReThink study: a 3-arm parallel randomized trial of cognitive bias modification, with and without adherence promotion, for adolescent anxiety disorder: trial design and protocol. BMC Psychiatry. 2019 10 22; 19(1):306.
Score: 0.040
-
Patient-based utilities for bipolar disorder-related health states. J Affect Disord. 2005 Aug; 87(2-3):203-10.
Score: 0.015